tirzepatide injectable Compound 1 and GIP therapy Compounded Injectable Tirzepatide

GH release is tied to a wide range of physiological processes, including tissue repair, lean mass maintenance, and metabolic regulation

Chest pain is a frequent symptom caused by pleural irritation from peripheral emboli causing pulmonary infarction or from right ventricular ischemia (13)

Cardiovascular effects: Phase 2 trial data indicate that retatrutide was associated with modest increases in resting heart rate, consistent with observations seen with other GLP-1 receptor agonists

Further, the diminished hearts capacity to pump blood in cases of dilated cardiomyopathy may lead to heart failure

Both cohorts had a higher proportion of female patients (82.53% vs